We are live on
!
Find out more
DE
DV Equities Portfolio holdings
AUM
$698M
This Fund
S&P 500
This Quarter
Est. Return
+26.77%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$698M
AUM Growth
–
Cap. Flow
+$656M
Cap. Flow
% of AUM
94.05%
Top 10 Holdings %
Top 10 Hldgs %
55.28%
Holding
107
New
107
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0.8
quarters
Top 10 Avg Time Held Equity + Options
0.1
quarters
Top 20 Avg Time Held Equity + Options
0.3
quarters
Avg Time Held Equity only
0.9
quarters
Top 10 Avg Time Held Equity only
0.1
quarters
Top 20 Avg Time Held Equity only
0.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$107M |
| 2 |
Sony
SONY
|
+$53.3M |
| 3 |
Honda
HMC
|
+$38.7M |
| 4 |
Tango Therapeutics
TNGX
|
+$32.6M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$30.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.81% |
| 2 | Healthcare | 23.04% |
| 3 | Technology | 14.71% |
| 4 | Consumer Discretionary | 7.78% |
| 5 | Communication Services | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
| $112M | 16% |
+1,347,857
| New | +$107M |
2026 Q2
0 quarters
|
|
|
2
Sony
SONY
$141B
| $50.7M | 7.27% |
+2,529,344
| New | +$53.3M |
2025 Q4
2 quarters
|
|
|
3
Tango Therapeutics
TNGX
$4.01B
| $41.2M | 5.91% |
+1,318,551
| New | +$32.6M |
2026 Q2
0 quarters
|
|
|
4
Honda
HMC
$42.4B
| $41.2M | 5.91% |
+1,520,344
| New | +$38.7M |
2026 Q2
0 quarters
|
|
5
iShares MSCI South Korea ETF
EWY
$25.4B
| $31.4M | 4.5% |
+155,525
| New | +$27.5M |
2026 Q2
0 quarters
|
|
|
NVO
6
Novo Nordisk
NVO
$171B
| $30.3M | 4.34% |
+631,226
| New | +$27.1M |
2025 Q4
2 quarters
|
|
|
7
iShares China Large-Cap ETF
FXI
$3.95B
| $27.2M | 3.9% |
+861,599
| New | +$30.7M |
2026 Q2
0 quarters
|
|
8
iShares MSCI EAFE ETF
EFA
$76.4B
| $19.2M | 2.75% |
+184,394
| New | +$19M |
2026 Q2
0 quarters
|
|
9
Pharvaris
PHVS
$2.18B
| $16.7M | 2.39% |
+482,524
| New | +$14.6M |
2026 Q2
0 quarters
|
|
10
iShares MSCI India ETF
INDA
$5.73B
| $16.1M | 2.31% |
+326,711
| New | +$15.9M |
2025 Q4
2 quarters
|
|
11
Micron Technology
MU
$1.16T
| $15M | 2.16% |
+13,025
| New | +$9.77M |
2025 Q4
2 quarters
|
|
12
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $14.6M | 2.09% |
+204,520
| New | +$14.2M |
2025 Q4
2 quarters
|
|
13
iShares MSCI Australia ETF
EWA
$1.22B
| $11.1M | 1.58% |
+392,549
| New | +$11.4M |
2025 Q4
2 quarters
|
|
14
iShares MSCI Japan Small-Cap ETF
SCJ
$242M
| $10.6M | 1.52% |
+100,394
| New | +$10.4M |
2026 Q2
0 quarters
|
|
15
Alphabet (Google) Class A
GOOGL
$4.3T
| $10.4M | 1.49% |
+29,054
| New | +$10.5M |
2025 Q4
2 quarters
|
|
16
Diageo
DEO
$48.2B
| $10.1M | 1.45% |
+125,998
| New | +$10.2M |
2026 Q2
0 quarters
|
|
17
BP
BP
$119B
| $10.1M | 1.45% |
+272,919
| New | +$12M |
2025 Q4
2 quarters
|
|
18
GSK
GSK
$93.2B
| $9.89M | 1.42% |
+188,762
| New | +$9.98M |
2025 Q4
2 quarters
|
|
19
iShares Core MSCI Total International Stock ETF
IXUS
$58.7B
| $9.54M | 1.37% |
+100,000
| New | +$9.4M |
2025 Q4
2 quarters
|
|
20
Microsoft
MSFT
$3.97T
| $9.49M | 1.36% |
+25,442
| New | +$10.3M |
2025 Q4
2 quarters
|
|
21
Revolution Medicines
RVMD
$40.7B
| $8.93M | 1.28% |
+47,666
| New | +$6.96M |
2026 Q2
0 quarters
|
|
|
MANE
22
Veradermics Inc
MANE
$5.47B
| $8.61M | 1.23% |
+70,000
| New | +$6.56M |
2026 Q2
0 quarters
|
|
23
ING
ING
$94.9B
| $7.51M | 1.08% |
+239,305
| New | +$7.08M |
2026 Q2
0 quarters
|
|
24
iShares Global Tech ETF
IXN
$9.85B
| $7.22M | 1.04% |
+50,000
| New | +$6.45M |
2025 Q4
2 quarters
|
|
|
SNDK
25
Sandisk
SNDK
$229B
| $6.36M | 0.91% |
+2,798
| New | +$3.99M |
2025 Q4
2 quarters
|
|
Similar funds
PGAM
SVCM
TFO
MAA
FA
CA
BWM
PA
DV Equities's Q2 2026 Portfolio in Review
As of Q2 2026, DV Equities held 107 positions worth $698M. Its ten largest holdings account for 55% of the portfolio.
DV Equities deployed $656M of net new capital in Q2 2026, opening 107 new positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,347,857 shares worth $112M.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, followed by Healthcare and Technology.
- DV Equities's largest Q2 2026 buy was iShares Core MSCI Emerging Markets ETF: 1,347,857 shares worth $112M.
- DV Equities's ten largest holdings make up 55% of its $698M portfolio in Q2 2026.
- DV Equities opened 107 new positions and closed 0 in Q2 2026.
Based on DV Equities's 13F filing for Q2 2026, filed 14 Aug 2026.